The role of collisions in rescuing stalled ribosomes in bacteria
- Institution
- Johns Hopkins University, MD
- Principal investigator
- Allen Rowdon Buskirk
- Funding
- $334K
- Duration
- 2021–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Translating ribosomes often encounter obstacles that stop them in their tracks. Ribosome quality control (RQC) pathways remove stalled ribosomes from mRNA so that they can be recycled. In the absence of RQC, bacteria are hypersensitive to many clinically important antibiotics that target the ribosome. The goal of this proposal is to determine molecular mechanisms of RQC in bacteria. In the last funding cycle, we established a new paradigm for how RQC factors in bacteria selectively recognize stalled ribosomes. When a trailing ribosome collides with a stalled ribosome, a unique interface forms between them, as revealed in cryo-EM structures of collided disomes from E. coli and B. subtilis solved in collaboration with Roland Beckmann. In E. coli, SmrB binds between collided disomes and cleaves the mRNA, targeting it for degradation. Any trailing ribosomes on the truncated mRNA are quickly rescued by the well-characterized tmRNA pathway. In B. subtilis, the SmrB homolog MutS2 lacks nuclease activity and instead uses ATP hydrolysis to split stalled ribosomes into subunits. Here we address three questions raised by our discovery that ribosome collisions trigger these two different RQC pathways in E. coli and B. subtilis. First, what advantage does splitting ribosomes into subunits have compared to rescuing them with tmRNA? We hypothesize that splitting is particularly important when ribosomes are inhibited by antibiotics, given that the tmRNA pathway requires active translation. In Aim 1, we will determine how E. coli cells split stalled ribosomes, building on our preliminary data identifying a novel RQC factor with ATPase activity. We will characterize this protein biochemically and observe its activity in vivo with ribosome profiling. Second, why does SmrB cleave mRNA in E. coli whereas MutS2 in B. subtilis does not? Our preliminary data suggest that mRNAs lacking a stop codon are rapidly decayed in E. coli but not in B. subtilis. Using sequencing approaches, in Aim 2 we will compare the effects of RQC factors on the transcriptome in E. coli and B. subtilis. In addition, we will use selective ribosome profiling to identify endogenous substrates for SmrB. Finally, ribosome collisions in eukaryotes lead to the activation of signaling pathways. Are there also regulatory events that take place on collided disomes in bacteria? In disome structures, the bL9 protein from the lead ribosome reaches back and contacts the trailing ribosome. By preventing the trailing ribosome from binding EFG and attempting translocation, bL9 may prevent frameshifting. In E. coli, bL9 is phosphorylated at sites that contact the trailing ribosome; we will test whether phosphorylation of bL9 changes its activity, if phosphorylation changes under various conditions, and identify the kinase responsible. These experiments will delineate molecular mechanisms of RQC pathways that rescue stalled ribosomes in bacteria.
LOADING MOONBASE SCORE
Questions for Johns Hopkins University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Johns Hopkins University72
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
Elham Hatef-Naimi · $611K · 2021–2025
- NIH · Johns Hopkins University66
Glucose instability and neurocognitive outcomes in older adults
Elizabeth Selvin · $697K · 2021–2027
- NSF · Johns Hopkins University65
Collaborative Research: CPS: Medium: Data Driven Modeling and Analysis of Energy Conversion Systems -- Manifold Learning and Approximation
Yannis Kevrekidis · $400K · 2023–2026